Diagnostic Performance of Immunohistochemistry Compared to Molecular Techniques for Microsatellite Instability and p53 Mutation Detection in Endometrial Cancer - 2023
Diagnostic Performance of Immunohistochemistry Compared to Molecular Techniques for Microsatellite Instability and p53 Mutation Detection in Endometrial Cancer
✱ These authors have contributed equally to this work.
Language :
English
Title :
Diagnostic Performance of Immunohistochemistry Compared to Molecular Techniques for Microsatellite Instability and p53 Mutation Detection in Endometrial Cancer
Sung H. Ferlay J. Siegel R.L. Laversanne M. Soerjomataram I. Jemal A. Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries CA Cancer J. Clin. 2021 71 209 249 10.3322/caac.21660 33538338
Gu B. Shang X. Yan M. Li X. Wang W. Wang Q. Zhang C. Variations in Incidence and Mortality Rates of Endometrial Cancer at the Global, Regional, and National Levels, 1990–2019 Gynecol. Oncol. 2021 161 573 580 10.1016/j.ygyno.2021.01.036 33551200
Cancer Genome Atlas Research Network. Kandoth C. Schultz N. Cherniack A.D. Akbani R. Liu Y. Shen H. Robertson A.G. Pashtan I. Shen R. et al. Integrated Genomic Characterization of Endometrial Carcinoma Nature 2013 497 67 73 10.1038/nature12113 23636398
Kommoss S. McConechy M.K. Kommoss F. Leung S. Bunz A. Magrill J. Britton H. Kommoss F. Grevenkamp F. Karnezis A. et al. Final Validation of the ProMisE Molecular Classifier for Endometrial Carcinoma in a Large Population-Based Case Series Ann. Oncol. 2018 29 1180 1188 10.1093/annonc/mdy058
WHO Classification of Tumours Editorial Board Female Genital Tumours 5th ed. IARC Publications Lyon, France 2020 Volume 4 978-92-832-4504-9
Concin N. Matias-Guiu X. Vergote I. Cibula D. Mirza M.R. Marnitz S. Ledermann J. Bosse T. Chargari C. Fagotti A. et al. ESGO/ESTRO/ESP Guidelines for the Management of Patients with Endometrial Carcinoma Int. J. Gynecol. Cancer 2021 31 12 39 10.1136/ijgc-2020-002230
Jamieson A. Bosse T. McAlpine J.N. The Emerging Role of Molecular Pathology in Directing the Systemic Treatment of Endometrial Cancer Ther. Adv. Med. Oncol. 2021 13 17588359211035960 10.1177/17588359211035959
Vermij L. Smit V. Nout R. Bosse T. Incorporation of Molecular Characteristics into Endometrial Cancer Management Histopathology 2020 76 52 63 10.1111/his.14015
Vermij L. Léon-Castillo A. Singh N. Powell M.E. Edmondson R.J. Genestie C. Khaw P. Pyman J. McLachlin C.M. Ghatage P. et al. P53 Immunohistochemistry in Endometrial Cancer: Clinical and Molecular Correlates in the PORTEC-3 Trial Mod. Pathol. 2022 35 1475 1483 10.1038/s41379-022-01102-x
León-Castillo A. de Boer S.M. Powell M.E. Mileshkin L.R. Mackay H.J. Leary A. Nijman H.W. Singh N. Pollock P.M. Bessette P. et al. Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy J. Clin. Oncol. 2020 38 3388 3397 10.1200/JCO.20.00549
Zannoni G.F. Bragantini E. Castiglione F. Fassan M. Troncone G. Inzani F. Pesci A. Santoro A. Fraggetta F. Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group Front. Oncol. 2022 12 805613 10.3389/fonc.2022.805613
Dedeurwaerdere F. Claes K.B. Van Dorpe J. Rottiers I. Van der Meulen J. Breyne J. Swaerts K. Martens G. Comparison of Microsatellite Instability Detection by Immunohistochemistry and Molecular Techniques in Colorectal and Endometrial Cancer Sci. Rep. 2021 11 12880 10.1038/s41598-021-91974-x 34145315
Singh N. Piskorz A.M. Bosse T. Jimenez-Linan M. Rous B. Brenton J.D. Gilks C.B. Köbel M. P53 Immunohistochemistry Is an Accurate Surrogate for TP53 Mutational Analysis in Endometrial Carcinoma Biopsies J. Pathol. 2020 250 336 345 10.1002/path.5375 31829441
McConechy M.K. Talhouk A. Li-Chang H.H. Leung S. Huntsman D.G. Gilks C.B. McAlpine J.N. Detection of DNA Mismatch Repair (MMR) Deficiencies by Immunohistochemistry Can Effectively Diagnose the Microsatellite Instability (MSI) Phenotype in Endometrial Carcinomas Gynecol. Oncol. 2015 137 306 310 10.1016/j.ygyno.2015.01.541 25636458
Raffone A. Travaglino A. Cerbone M. De Luca C. Russo D. Di Maio A. De Marco M. Turco M.C. Insabato L. Zullo F. Diagnostic Accuracy of P53 Immunohistochemistry as Surrogate of TP53 Sequencing in Endometrial Cancer Pathol. Res. Pract. 2020 216 153025 10.1016/j.prp.2020.153025 32703491
Raffone A. Travaglino A. Cerbone M. Gencarelli A. Mollo A. Insabato L. Zullo F. Diagnostic Accuracy of Immunohistochemistry for Mismatch Repair Proteins as Surrogate of Microsatellite Instability Molecular Testing in Endometrial Cancer Pathol. Oncol. Res. 2020 26 1417 1427 10.1007/s12253-020-00811-5 32377987
Beinse G. Rance B. Just P.-A. Izac B. Letourneur F. Saidu N.E.B. Chouzenoux S. Nicco C. Goldwasser F. Batteux F. et al. Identification of TP53 Mutated Group Using a Molecular and Immunohistochemical Classification of Endometrial Carcinoma to Improve Prognostic Evaluation for Adjuvant Treatments Int. J. Gynecol. Cancer 2020 30 640 647 10.1136/ijgc-2019-000871
Jamieson A. Barroilhet L.M. McAlpine J.N. Molecular Classification in Endometrial Cancer: Opportunities for Precision Oncology in a Changing Landscape Cancer 2022 128 2853 2857 10.1002/cncr.34328
Ferguson S.E. Aronson M. Pollett A. Eiriksson L.R. Oza A.M. Gallinger S. Lerner-Ellis J. Alvandi Z. Bernardini M.Q. MacKay H.J. et al. Performance Characteristics of Screening Strategies for Lynch Syndrome in Unselected Women with Newly Diagnosed Endometrial Cancer Who Have Undergone Universal Germline Mutation Testing Cancer 2014 120 3932 3939 10.1002/cncr.28933
Modica I. Soslow R.A. Black D. Tornos C. Kauff N. Shia J. Utility of Immunohistochemistry in Predicting Microsatellite Instability in Endometrial Carcinoma Am. J. Surg. Pathol. 2007 31 744 751 10.1097/01.pas.0000213428.61374.06
Singh N. Wong R. Tchrakian N. Allen S.-G. Clarke B. Gilks C.B. Interpretation and Reporting Terminology for Mismatch Repair Protein Immunochemistry in Endometrial Cancer. BAGP Guidance Document: MMR Immunohistochemistry Interpretation and Terminology. Version 1.1. June 2020 Available online: https://www.thebagp.org/wp-content/uploads/download-manager-files/1593411202wpdm_BAGP%20MMR%20IHC%20Interpretation%20June%202020.pdf (accessed on 21 September 2022)
Zannoni G.F. Santoro A. D’Alessandris N. Scaglione G. Inzani F. Angelico G. Bragantini E. Piermattei A. Cianfrini F. Bisaro B. et al. Biomarker Characterization in Endometrial Cancer in Italy: First Survey Data Analysis Pathologica 2022 114 189 198 10.32074/1591-951X-775
Landis J.R. Koch G.G. The Measurement of Observer Agreement for Categorical Data Biometrics 1977 33 159 174 10.2307/2529310 843571
McCarthy A.J. Capo-Chichi J.-M. Spence T. Grenier S. Stockley T. Kamel-Reid S. Serra S. Sabatini P. Chetty R. Heterogenous Loss of Mismatch Repair (MMR) Protein Expression: A Challenge for Immunohistochemical Interpretation and Microsatellite Instability (MSI) Evaluation J. Pathol. Clin. Res. 2019 5 115 129 10.1002/cjp2.120 30387329
Nolano A. Medugno A. Trombetti S. Liccardo R. De Rosa M. Izzo P. Duraturo F. Hereditary Colorectal Cancer: State of the Art in Lynch Syndrome Cancers 2022 15 75 10.3390/cancers15010075 36612072
Leclerc J. Vermaut C. Buisine M.-P. Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI/DMMR Tumors Cancers 2021 13 467 10.3390/cancers13030467
Köbel M. Ronnett B.M. Singh N. Soslow R.A. Gilks C.B. McCluggage W.G. Interpretation of P53 Immunohistochemistry in Endometrial Carcinomas: Toward Increased Reproducibility Int. J. Gynecol. Pathol. 2019 38 (Suppl. S1) S123 S131 10.1097/PGP.0000000000000488
Wing-Cheuk Wong R. Palicelli A. Hoang L. Singh N. Interpretation of P16, P53 and Mismatch Repair Protein Immunohistochemistry in Gynaecological Neoplasia Diagn. Histopathol. 2020 26 257 277 10.1016/j.mpdhp.2020.03.002
Köbel M. Piskorz A.M. Lee S. Lui S. LePage C. Marass F. Rosenfeld N. Mes Masson A.-M. Brenton J.D. Optimized P53 Immunohistochemistry Is an Accurate Predictor of TP53 Mutation in Ovarian Carcinoma J. Pathol. Clin. Res. 2016 2 247 258 10.1002/cjp2.53
Nakamura M. Obata T. Daikoku T. Fujiwara H. The Association and Significance of P53 in Gynecologic Cancers: The Potential of Targeted Therapy Int. J. Mol. Sci. 2019 20 5482 10.3390/ijms20215482
Obata T. Nakamura M. Mizumoto Y. Iizuka T. Ono M. Terakawa J. Daikoku T. Fujiwara H. Dual Expression of Immunoreactive Estrogen Receptor β and P53 Is a Potential Predictor of Regional Lymph Node Metastasis and Postoperative Recurrence in Endometrial Endometrioid Carcinoma PLoS OsNE 2017 12 e0188641 10.1371/journal.pone.0188641
Köbel M. McCluggage W.G. Gilks C.B. Singh N. Interpretation of P53 Immunohistochemistry In Tubo-Ovarian Carcinoma: Guidelines for Reporting. BAGP Guidance Document: P53 IHC Reporting in Tubo-Ovarian Carcinoma. Version 1.0. October 2016 Available online: https://www.bgcs.org.uk/wp-content/uploads/2019/06/BAGP-UKNEQAS-project-p53-interpretation-guide-2016.pdf (accessed on 27 October 2022)
León-Castillo A. Gilvazquez E. Nout R. Smit V.T. McAlpine J.N. McConechy M. Kommoss S. Brucker S.Y. Carlson J.W. Epstein E. et al. Clinicopathological and Molecular Characterisation of ‘Multiple-classifier’ Endometrial Carcinomas J. Pathol. 2020 250 312 322 10.1002/path.5373
Betella I. Fumagalli C. Rafaniello Raviele P. Schivardi G. De Vitis L.A. Achilarre M.T. Aloisi A. Garbi A. Maruccio M. Zanagnolo V. et al. A Novel Algorithm to Implement the Molecular Classification According to the New ESGO/ESTRO/ESP 2020 Guidelines for Endometrial Cancer Int. J. Gynecol. Cancer 2022 32 993 1000 10.1136/ijgc-2022-003480 35732351
Singh N. Jamieson A. Morrison J. Taylor A. Ganesan R. BAGP Guidance on POLE NGS Testing in Endometrial Carcinoma. Version 1.2. July 2022 Available online: https://www.thebagp.org/wp-content/uploads/download-manager-files/BAGP-POLE-testing-in-Endometrial-cancer-v1.2-July-2022.pdf (accessed on 27 October 2022)
Jamieson A. Lum A. Leung S. Thompson E. Senz J. Talhouk A. Bashashati A. Huntsman D. McConechy M. McAlpine J. O005/#638 ProMisE-2: A One Step DNA-Based Endometrial Cancer Molecular Classifier Proceedings of the IGCS 2022 Abstracts: Oral Abstract Presentations (Plenary Sessions)-Plenary 01: Opening Ceremony and Oral Abstract Presentations New York, NY, USA 29 September 2022
Park J.H. Kim E.Y. Luchini C. Eccher A. Tizaoui K. Shin J.I. Lim B.J. Artificial Intelligence for Predicting Microsatellite Instability Based on Tumor Histomorphology: A Systematic Review Int. J. Mol. Sci. 2022 23 2462 10.3390/ijms23052462 35269607
Luchini C. Pea A. Scarpa A. Artificial Intelligence in Oncology: Current Applications and Future Perspectives Br. J. Cancer 2022 126 4 9 10.1038/s41416-021-01633-1 34837074
Sultan A.S. Elgharib M.A. Tavares T. Jessri M. Basile J.R. The Use of Artificial Intelligence, Machine Learning and Deep Learning in Oncologic Histopathology J. Oral Pathol. Med. 2020 49 849 856 10.1111/jop.13042 32449232
Suraweera N. Duval A. Reperant M. Vaury C. Furlan D. Leroy K. Seruca R. Iacopetta B. Hamelin R. Evaluation of Tumor Microsatellite Instability Using Five Quasimonomorphic Mononucleotide Repeats and Pentaplex PCR Gastroenterology 2002 123 1804 1811 10.1053/gast.2002.37070 12454837
Buhard O. Suraweera N. Lectard A. Duval A. Hamelin R. Quasimonomorphic Mononucleotide Repeats for High-Level Microsatellite Instability Analysis Dis. Mrk. 2004 20 251 257 10.1155/2004/159347
